Inactivation of P53 predisposes to dysregulated proliferation and aberrantly prolonged survival of mutated cells (Evan and Littlewood, 1998) and this is reflected in the high frequency of P53 inactivation in human cancers (Harris and Hollstein, 1993). This evidence concerns the gene TP53 and cancer.